StonvexLoading…
StonvexStonvexStonvexCore line items from ALAB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $852.52M | $396.29M | $115.79M | $79.87M |
Operating Income | $173.42M | $-116.07M | $-29.50M | $-60.19M |
Net Income | $219.13M | $-83.42M | $-26.26M | $-58.34M |
EPS (Diluted) | $1.22 | $-0.64 | $-0.71 | $-1.71 |
Total Assets | $1.53B | $1.05B | $196.29M | Not available |
Total Liabilities | $168.19M | $89.71M | $38.87M | Not available |
Cash & Equivalents | $167.61M | $79.55M | $45.10M | $76.09M |
Free Cash Flow OCF − CapEx | $281.76M | $102.43M | $-15.48M | $-39.77M |
Shares Outstanding | 170.19M | 162.02M | 42.05M | 34.17M |